Globus Medical, Inc. NYQ · GMED
Price alert —
Sign in to get a one-time email the moment GMED crosses your price. Free accounts included.
Sign in / create a free accountGlobus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally.
GMED last traded at $77.00, down 4.8% on the day; that's in the lower part of its 52-week range ($74.39–$97.87). Right now it's dipped below its recent average — a spot where watchers often look for signs the dip is stabilizing.
The next scheduled earnings report (2026-08-06) is the biggest known catalyst on the calendar, and after the recent dip, watch whether the price stops making lower lows before assuming the worst is over.
A plain-English snapshot built from the data on this page — not investment advice. Always do your own research.
below KC1 upper, -0.62 ATR from EMA21 — no notable pattern
Each bar shows how many points that factor added. The more points — and the more factors that agree — the higher the letter grade.
- · Aligned with weak downtrend
Each bar shows how many points that factor added. The more points — and the more factors that agree — the higher the letter grade.
Our cash-flow model pegs fair value near $170.77 (fair range $60–$171); today's price leaves a +55% cushion below that estimate. The model's verdict is “Deep value” and accounting quality screens as Strong. Model estimates only — do your own due diligence.
- ✓ More cash than debt
- ✓ Quick ratio 2.63 (antifragile)
- ✓ Current ratio 4.26 (antifragile)
- ✓ Debt/equity 0.16 (antifragile)
- ⚠ Receivables growing faster than revenue
Price implies ~10% growth (vs trailing rev yoy). Model estimate — do your own due diligence.
GMED is a $10.5 billion company, priced at 18× last year's earnings, and the stock is trading near the bottom of its 52-week range.
Options idea
See more →Earnings
See more →- Last reported
- 2026-05-07
- EPS (act / est)
- 1.12 / 0.92
- Surprise
- +21.7%
- Next report
- 2026-08-06
About
Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation tech…